Influence of microglial activation on neuronal function in Alzheimer's and Parkinson's disease dementia

Alzheimer's and Dementia

Volumn 11, Issue 6, 2015, Pages 608-621.e7

  Fan, Zhen ^a   Aman, Yahyah ^a   Ahmed, Imtiaz ^a   Chetelat, Gaël ^b   Landeau, Brigitte ^b   Ray Chaudhuri, K ^c   Brooks, David J ^a   Edison, Paul ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b UNIVERSITÉ DE CAEN   (France)

^c KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Alzheimer's disease; Correlation; FDG; Mild cognitive impairment; Parkinson's disease dementia; PIB; PK11195

Indexed keywords

FLUORODEOXYGLUCOSE F 18; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE C 11; PITTSBURGH COMPOUND B; AMYLOID; CARBON; GLUCOSE; ISOQUINOLINE DERIVATIVE; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN REGION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE METABOLISM; HUMAN; MACROPHAGE ACTIVATION; MALE; MICROGLIA; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; NERVOUS SYSTEM INFLAMMATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; BRAIN; BRAIN MAPPING; COGNITIVE DEFECT; DIAGNOSTIC IMAGING; IMMUNOLOGY; METABOLISM; NEUROPSYCHOLOGICAL TEST; PATHOLOGY; SIGNAL PROCESSING;

ALZHEIMER DISEASE; AMYLOID; BRAIN; BRAIN MAPPING; CARBON RADIOISOTOPES; COGNITIVE DYSFUNCTION; FLUORODEOXYGLUCOSE F18; GLUCOSE; HUMANS; ISOQUINOLINES; MAGNETIC RESONANCE IMAGING; MICROGLIA; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; SIGNAL PROCESSING, COMPUTER-ASSISTED;

EID: 84931577112     PISSN: 15525260     EISSN: 15525279     Source Type: Journal    
DOI: 10.1016/j.jalz.2014.06.016     Document Type: Article

References (43)

1. R.C. Petersen, R. Doody, A. Kurz, R.C. Mohs, J.C. Morris, P.V. Rabins, et al. Current concepts in mild cognitive impairment Arch Neurol 58 2001 1985 1992
2. T.A. Hughes, H.F. Ross, S. Musa, S. Bhattacherjee, R.N. Nathan, R.H. Mindham, et al. A 10-year study of the incidence of and factors predicting dementia in Parkinson's disease Neurology 54 2000 1596 1602
3. J.L. Cummings Intellectual impairment in Parkinson's disease: clinical, pathologic, and biochemical correlates J Geriatr Psychiatry Neurol 1 1988 24 36
4. S. Amor, F. Puentes, D. Baker, and P. van der Valk Inflammation in neurodegenerative diseases Immunology 129 2010 154 169
5. T.C. Frank-Cannon, L.T. Alto, F.E. McAlpine, and M.G. Tansey Does neuroinflammation fan the flame in neurodegenerative diseases? Mol Neurodegen 4 2009
6. Y. Ouchi, S. Yagi, M. Yokokura, and M. Sakamoto Neuroinflammation in the living brain of Parkinson's disease Parkinsonism Relat Disord 15 Suppl 3 2009 S200 S204
7. H.M. Gao, and J.S. Hong Why neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progression Trends Immunol 29 2008 357 365
8. W.J. Streit, R.E. Mrak, and W.S. Griffin Microglia and neuroinflammation: a pathological perspective J Neuroinflammation 1 2004 14
9. P.L. McGeer, S. Itagaki, B.E. Boyes, and E.G. McGeer Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains Neurology 38 1988 1285 1291
10. P. Edison, H.A. Archer, A. Gerhard, R. Hinz, N. Pavese, F.E. Turkheimer, et al. Microglia, amyloid, and cognition in Alzheimer's disease: an [11C](R)PK11195-PET and [11C]PIB-PET study Neurobiol Dis 32 2008 412 419
11. A. Okello, P. Edison, H.A. Archer, F.E. Turkheimer, J. Kennedy, R. Bullock, et al. Microglial activation and amyloid deposition in mild cognitive impairment: a PET study Neurology 72 2009 56 62
12. P. Edison, C.C. Rowe, J.O. Rinne, S. Ng, I. Ahmed, N. Kemppainen, et al. Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography J Neurol Neurosurg Psychiatry 79 2008 1331 1338
13. A. Okello, J. Koivunen, P. Edison, H.A. Archer, F.E. Turkheimer, K. Nagren, et al. Conversion of amyloid positive and negative MCI to AD over 3 years: an 11C-PIB PET study Neurology 73 2009 754 760
14. P. Edison, H.A. Archer, R. Hinz, A. Hammers, N. Pavese, Y.F. Tai, et al. Amyloid, hypometabolism, and cognition in Alzheimer disease: an [11C]PIB and [18F]FDG PET study Neurology 68 2007 501 508
15. F.E. Turkheimer, P. Edison, N. Pavese, F. Roncaroli, A.N. Anderson, A. Hammers, et al. Reference and target region modeling of [11C]-(R)-PK11195 brain studies J Nucl Med 48 2007 158 167
16. A.N. Anderson, N. Pavese, P. Edison, Y.F. Tai, A. Hammers, A. Gerhard, et al. A systematic comparison of kinetic modelling methods generating parametric maps for [(11)C]-(R)-PK11195 Neuroimage 36 2007 28 37
17. M.T. Hu, S.D. Taylor-Robinson, K.R. Chaudhuri, J.D. Bell, C. Labbe, V.J. Cunningham, et al. Cortical dysfunction in non-demented Parkinson's disease patients: a combined (31)P-MRS and (18)FDG-PET study Brain 123 Pt 2 2000 340 352
18. V.J. Cunningham, and T. Jones Spectral analysis of dynamic PET studies J Cereb Blood Flow Metab 13 1993 15 23
19. G. Riedel, P. Fadda, S. McKillop-Smith, R.G. Pertwee, B. Platt, and L. Robinson Synthetic and plant-derived cannabinoid receptor antagonists show hypophagic properties in fasted and non-fasted mice Br J Pharmacol 156 2009 1154 1166
20. P. Edison, I. Ahmed, Z. Fan, R. Hinz, G. Gelosa, K. Ray Chaudhuri, et al. Microglia, amyloid, and glucose metabolism in Parkinson's disease with and without dementia Neuropsychopharmacology 38 2013 938 949
21. A. Kumar, B.A. Stoica, B. Sabirzhanov, M.P. Burns, A.I. Faden, and D.J. Loane Traumatic brain injury in aged animals increases lesion size and chronically alters microglial/macrophage classical and alternative activation states Neurobiol Aging 34 2013 1397 1411
22. M.A. Yenari, T.M. Kauppinen, and R.A. Swanson Microglial activation in stroke: therapeutic targets Neurotherapeutics 7 2010 378 391
23. A.B. Rocher, F. Chapon, X. Blaizot, J.C. Baron, and C. Chavoix Resting-state brain glucose utilization as measured by PET is directly related to regional synaptophysin levels: a study in baboons Neuroimage 20 2003 1894 1898
24. W. Jagust, B. Reed, D. Mungas, W. Ellis, and C. Decarli What does fluorodeoxyglucose PET imaging add to a clinical diagnosis of dementia? Neurology 69 2007 871 877
25. C. Habeck, S. Risacher, G.J. Lee, M.M. Glymour, E. Mormino, S. Mukherjee, et al. Relationship between baseline brain metabolism measured using [(1)(8)F]FDG PET and memory and executive function in prodromal and early Alzheimer's disease Brain Imaging Behav 6 2012 568 583
26. W.J. Streit Microglia and Alzheimer's disease pathogenesis J Neurosci Res 77 2004 1 8
27. C. Holmes Review: systemic inflammation and Alzheimer's disease Neuropathol Appl Neurobiol 39 2013 51 68
28. M. Yokokura, N. Mori, S. Yagi, E. Yoshikawa, M. Kikuchi, Y. Yoshihara, et al. In vivo changes in microglial activation and amyloid deposits in brain regions with hypometabolism in Alzheimer's disease Eur J Nucl Med Mol Imaging 38 2011 343 351
29. A. Kadir, A. Marutle, D. Gonzalez, M. Scholl, O. Almkvist, M. Mousavi, et al. Positron emission tomography imaging and clinical progression in relation to molecular pathology in the first Pittsburgh compound B positron emission tomography patient with Alzheimer's disease Brain 134 2011 301 317
30. V.H. Perry, J.A. Nicoll, and C. Holmes Microglia in neurodegenerative disease Nat Rev Neurol 6 2010 193 201
31. S. Prokop, K.R. Miller, and F.L. Heppner Microglia actions in Alzheimer's disease Acta Neuropathol 126 2013 461 477
32. P.L. McGeer, and E.G. McGeer Local neuroinflammation and the progression of Alzheimer's disease J Neurovirol 8 2002 529 538
33. Y.N. Zhao, F. Wang, Y.X. Fan, G.F. Ping, J.Y. Yang, and C.F. Wu Activated microglia are implicated in cognitive deficits, neuronal death, and successful recovery following intermittent ethanol exposure Behav Brain Res 236 2013 270 282
34. K.J. Doorn, P.J. Lucassen, H.W. Boddeke, M. Prins, H.W. Berendse, B. Drukarch, et al. Emerging roles of microglial activation and non-motor symptoms in Parkinson's disease Prog Neurobiol 98 2012 222 238
35. J. Scheffel, T. Regen, D. Van Rossum, S. Seifert, S. Ribes, R. Nau, et al. Toll-like receptor activation reveals developmental reorganization and unmasks responder subsets of microglia Glia 60 2012 1930 1943
36. M. Fiala, and R. Veerhuis Biomarkers of inflammation and amyloid-beta phagocytosis in patients at risk of Alzheimer disease Exp Gerontol 45 2010 57 63
37. C.R. Jack Jr., D.S. Knopman, W.J. Jagust, L.M. Shaw, P.S. Aisen, M.W. Weiner, et al. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade Lancet Neurol 9 2010 119 128
38. D.J. Irwin, V.M. Lee, and J.Q. Trojanowski Parkinson's disease dementia: convergence of alpha-synuclein, tau and amyloid-beta pathologies Nat Rev Neurosci 14 2013 626 636
39. S. Lavisse, M. Guillermier, A.S. Herard, F. Petit, M. Delahaye, N. Van Camp, et al. Reactive astrocytes overexpress TSPO and are detected by TSPO positron emission tomography imaging J Neurosci 32 2012 10809 10818
40. C.R. Figley, and P.W. Stroman The role(s) of astrocytes and astrocyte activity in neurometabolism, neurovascular coupling, and the production of functional neuroimaging signals Eur J Neurosci 33 2011 577 588
41. J. Chuquet, P. Quilichini, E.A. Nimchinsky, and G. Buzsaki Predominant enhancement of glucose uptake in astrocytes versus neurons during activation of the somatosensory cortex J Neurosci 30 2010 15298 15303
42. M. Belanger, I. Allaman, and P.J. Magistretti Brain energy metabolism: focus on astrocyte-neuron metabolic cooperation Cell Metab 14 2011 724 738
43. I. Allaman, M. Gavillet, M. Belanger, T. Laroche, D. Viertl, H.A. Lashuel, et al. Amyloid-beta aggregates cause alterations of astrocytic metabolic phenotype: impact on neuronal viability J Neurosci 30 2010 3326 3338